Table 3: Distribution of most significant markers in men and women with PsA.
(a)

MarkerPsA females: 55Female controls: 55

HLA-C*0631 (56.4%)
OR: 6.6 (2.7–16.1),
9 (16.4%)
HLA-C*0727 (49%)
OR: 2.8 (1.3–6.3),
14 (25.5%)
TNF-308A25 (45.5%)
OR: 3.0 (1.3–6.9),
12 (22%)
MICA-A933 (60%)
OR: 3.1 (1.4–6.7),
18 (32.7%)
HLA-B*2715 (27.3%)
OR: 4.8 (1.5–15.5),
4 (7.3%)

(b)

Marker PsA males: 55Male controls: 55

HLA-C*0631 (56.4%)
OR: 5.8 (2.4–13.8),
10 (18.2%)
MICA-A9
33 (60%)
OR: 4.0 (1.8–8.9),
15 (27.3%)
HLA-B*2720 (36.4%)
OR: 7.3 (2.3–23.2),
4 (7.3%)